Form 4: VolitionRx Director Phillip Barnes Acquires Shares in Lieu of Cash Compensation

Director Phillip Barnes acquired 8,011 shares of VolitionRx Ltd. common stock on June 1, 2024, in lieu of cash compensation.

Summary

• On June 1, 2024, Phillip Barnes, a director of VolitionRx Ltd., acquired 8,011 shares of common stock.
• The acquisition was in the form of restricted stock units (RSUs) awarded under the company's 2015 Stock Incentive Plan.
• These RSUs were granted in lieu of cash compensation that would have otherwise been owed to Mr. Barnes.
• The RSUs vest in three installments of 2,671, 2,670, and 2,670 units on June 1, 2024, July 1, 2024, and August 1, 2024, respectively.
• The RSUs are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date.
• Following the transaction, Mr. Barnes directly owns 41,197 shares of VolitionRx Ltd.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking compensation in stock aligns interests with shareholders, which is generally viewed favorably. There are no indications of negative news or concerns.

Positives

• A director taking compensation in stock aligns their interests with shareholders.
• The vesting schedule encourages continued service and commitment from the director.

Industry Context

Directors receiving stock-based compensation is a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation for directors is a standard practice across the biotechnology industry.
• Companies like Exact Sciences and Guardant Health also utilize stock options and RSUs as part of their director compensation packages.
• The vesting schedules and amounts are generally determined based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it aligns the director's interests with theirs.
• Employees may view this as a positive sign of management's commitment to the company's long-term success.

Key Dates